Longgui Wang
10Patents
3h-index
7Co-inventors
49Inventor score
Filing activity: Dec 13, 2001 → Jun 6, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9040574B2 | Method of treating androgen independent prostate cancer | Human Necessities | 1,030 | Active |
| US6933315B2 | Derivatives of isoindigo, indigo and indirubin and methods of treating cancer | Chemistry; Metallurgy | 11 | Expired |
| US6566341B1 | Derivative of isoindigo, indigo and indirubin for the treatment of cancer | Human Necessities | 7 | Expired |
| US7582670B2 | Methods of treating an inflammatory-related disease | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9962400B2 | Methods and compositions for treating lupus | Human Necessities | 1 | Active |
| US8563525B2 | Methods of treating an inflammatory-related disease | Emerging Cross-Sectional Technologies | 1 | Active |
| US7855223B2 | Method of treating inflammatory arthritis | Emerging Cross-Sectional Technologies | 1 | Active |
| US9023885B2 | Methods of treating an inflammatory-related disease | Emerging Cross-Sectional Technologies | 1 | Active |
| US8748475B2 | Methods and compositions for treating lupus | Human Necessities | 1 | Active |
| US8394847B2 | Methods of treating an inflammatory-related disease | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.